In line with our results, silencing of BMI-1 in breast cancer cells was shown to impair Wnt signalling via downregulation of Wnt ligands (e.g. Wnt3a) and upregulation of Wnt inhibitors including DKK1. The gene discussed is DKK1; the disease is breast cancer.